98%
921
2 minutes
20
Background: Recent developments in technologies have offered opportunities to measure the exposome with unprecedented accuracy and scale. However, because most investigations have targeted only a few exposures at a time, it is hypothesized that the majority of the environmental determinants of chronic diseases remain unknown.
Objectives: We describe a functional exposome concept and explain how it can leverage existing bioassays and high-resolution mass spectrometry for exploratory study. We discuss how such an approach can address well-known barriers to interpret exposures and present a vision of next-generation exposomics.
Discussion: The exposome is vast. Instead of trying to capture all exposures, we can reduce the complexity by measuring the functional exposome-the totality of the biologically active exposures relevant to disease development-through coupling biochemical receptor-binding assays with affinity purification-mass spectrometry. We claim the idea of capturing exposures with functional biomolecules opens new opportunities to solve critical problems in exposomics, including low-dose detection, unknown annotations, and complex mixtures of exposures. Although novel, biology-based measurement can make use of the existing data processing and bioinformatics pipelines. The functional exposome concept also complements conventional targeted and untargeted approaches for understanding exposure-disease relationships.
Conclusions: Although measurement technology has advanced, critical technological, analytical, and inferential barriers impede the detection of many environmental exposures relevant to chronic-disease etiology. Through biology-driven exposomics, it is possible to simultaneously scale up discovery of these causal environmental factors. https://doi.org/10.1289/EHP8327.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388254 | PMC |
http://dx.doi.org/10.1289/EHP8327 | DOI Listing |
Arch Toxicol
September 2025
National Institutes for Food and Drug Control, Beijing, 100050, China.
Traditional toxicological paradigms, reliant on animal testing and simplistic in vitro models, face significant limitations, including prolonged timelines, high costs, and poor translational predictability due to interspecies differences. This review highlights the transformative potential of New Approach Methodologies (NAMs) in overcoming these challenges. Key advancements include Organ-on-a-Chip (OoC) platforms that emulate human organ physiology and multi-organ crosstalk, significantly improving predictive accuracy.
View Article and Find Full Text PDFEur J Neurol
September 2025
RECETOX, Faculty of Science, Masaryk University, Brno, Czech Republic.
Background: Evidence on the relationship between physical and cognitive functions remains inconsistent, and the role of sex differences is underexplored. This study examines the predictive value of a composite Physical Functioning Score (PFS) for cognitive function and assesses sex-specific associations in an Eastern European population.
Methods: Data from 7309 participants (mean age 59 ± 7.
Neuroscience
August 2025
School of Nursing, Psychotherapy and Community Health, Dublin City University, Ireland; Institute of Population Health, School of Medicine, Trinity College, The University of Dublin, Ireland; Global Brain Health Institute, University of California San Francisco, San Francisco, CA, USA; Trinity Colle
Age-related hearing loss (ARHL) has emerged as a significant and potentially modifiable risk factor for neurodegenerative disorders, including Alzheimer's disease. A growing body of evidence links ARHL to structural and functional changes in the brain, with implications for cognitive decline and dementia onset. However, both ARHL and dementia are multifactorial conditions shaped not only by biological mechanisms but also by broader social determinants of health.
View Article and Find Full Text PDFInt J Mol Sci
August 2025
Division of Preventive Medicine, Dresden International University (DIU), 01067 Dresden, Germany.
Longevity and healthy aging result from the complex interaction of genetic, epigenetic, microbial, behavioral, and environmental factors. The central nervous system-particularly the cerebral cortex-and the autonomic nervous system (ANS) play key roles in integrating external and internal signals, shaping energy metabolism, immune tone, and emotional regulation. This narrative review examines how the brain-ANS axis interacts with epigenetic regulation, telomere dynamics, the gut microbiome, and the exposome to influence biological aging and resilience.
View Article and Find Full Text PDFAm J Epidemiol
August 2025
Department of Epidemiology and Biostatistics, University of California, San Francisco.
We examined the independent and joint associations of five key social exposome components, including financial strain, neighborhood disorder, perceived discrimination, social strain, and traumatic life events, with cognitive function levels and decline. Data were from adults aged > 50 in the US Health and Retirement Study (HRS; n=13,795; 2008-2020) and the English Longitudinal Study of Ageing (ELSA; n=9,469; 2006-2019), and adults aged ≥ 65 in their Harmonized Cognitive Assessment Protocol (HCAP) subsamples (HRS-HCAP: n=2,749; 2016; ELSA-HCAP: n=955; 2018). Using linear mixed-effects models and quantile-based g-computation, we found that all components, except traumatic life events, were associated with lower cognitive function.
View Article and Find Full Text PDF